Patent details

Basic Information

Publication number:

EP1931315

PCT Application Number:

PCT/US/2006/033011

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP067899641

PCT Publication Number:

WO/2007/025005

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SUSTAINED RELEASE FORMULATIONS OF NALBUPHINE

French Title of Invention:

FORMULATIONS DE NALBUPHINE A LIBERATION PROLONGEE

German Title of Invention:

NALBUPHIN-FORMULIERUNGEN MIT VERZÖGERTER FREISETZUNG

SPC Number:

Dates

Filing date:

24/08/2006

Grant date:

16/10/2013

EP Publication Date:

16/10/2013

PCT Publication Date:

01/03/2007

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/06/2008

EP B1 Publication Date:

16/10/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

24/08/2014

Expiration date:

24/08/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/12/2013

 

 

Name:

Endo Pharmaceuticals Inc.

Address:

1400 Atwater Drive, Malvern, PA 19355, United States (US)

Inventor

1

Name:

SCIASCIA Thomas

Address:

United States (US)

2

Name:

VOGLER Brian

Address:

United States (US)

3

Name:

CARPANZANO Anthony, E.

Address:

United States (US)

4

Name:

BAICHWAL Anand, R.

Address:

United States (US)

5

Name:

DIEHL Donald, II

Address:

United States (US)

6

Name:

GOLIBER Philip, A.

Address:

United States (US)

Priority

1

Priority Number:

710772 P

Priority Date:

24/08/2005

Priority Country:

United States (US)

2

Priority Number:

772466 P

Priority Date:

10/02/2006

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/20;

Filing date	Document type	Number of pages